This selective estrogen receptor modulator (SERM) blocks the effects of estrogen in breast cancer cells by competitively interacting with the estrogen receptor (ER), thus preventing ER-mediated transcription through estrogen response elements of various genes. This evidence concerns the gene ESR1 and breast carcinoma.